Donald Trump reverses the vaccination decision of the White House as rollout begins in other areas of the United States


As the roll-out starts elsewhere in the U.S., Donald Trump has reversed his decision for White House officials to obtain the vaccine in the coming days.

Officials had previously claimed that senior Trump administration officials were among the first in line expected to obtain the Pfizer/BioNTech vaccine, but Trump has now reversed that decision, stating that White House workers could receive the vaccine “a little later…. unless specifically necessary.”

“I asked for that adjustment to be made,”I asked for that adjustment to be made.

Why the decision to vaccinate early was reversed is unclear.

Mr. Trump also indicated that the vaccine was “not scheduled” to be received, but that he would “look forward to doing so in due course.”

Individuals working in the White House, unless expressly needed, should receive the vaccine slightly later in the program. I asked for this change to be made. I do not wish to be vaccinated, but I look forward to getting vaccinated in due course. Hey, thank you.
December 14, 2020 — Donald J. Trump (@realDonaldTrump)

In other areas of the U.S., meanwhile, the distribution of the vaccine has begun, with the first three million doses delivered in all 50 states.

The Pfizer/BioNTech vaccine, which is 95% safe, earned approval from the U.S. on Friday. Health and Drug Administration for emergency use – planned to be among the first vaccinated for healthcare staff and nursing home residents.

Initial administration of a vaccine. Congratulations USA! Congratulations USA! Congratulations WORLD!
December 14, 2020 — Donald J. Trump (@realDonaldTrump)

President Donald Trump said in a video statement late Friday that Pfizer had achieved “the gold standard of safety” and hailed the vaccine as “one of the greatest scientific achievements in history.”

He added: “Today, our nation has achieved a medical miracle.

“We have delivered a safe and effective vaccine in just nine months.”

About three million doses of the vaccine are expected in the first shipments, with a similar amount held in reserve for the second doses.


Leave A Reply